EU nudges Japan towards regulatory reforms
This article was originally published in Scrip
Executive Summary
Pharmaceutical and vaccine issues were again high on the agenda at the latest round of talks in the EU and Japan's long-running dialogue on regulatory reform. The European side is continuing to push for a number of fundamental changes and business groups are calling for a free trade agreement which would include the mutual recognition of marketing authorisations.